International
Brasil 
Chile 
Deutschland 
España 
France 
Italia 
Panamá 
Portugal 
Russia 
UK 
IVI will refund women and couples who do not manage to have a baby as a result of IVI Baby IVI BABY utilizes the latest advances in technology and science to maximize chance of success for infertility patients The quality of the medical protocols, advanced laboratories with state-of-the-art technology and highly qualified professionals together enable… View Article
• The SRI-Pfizer Award recognizes the best 25 papers presented by researchers in training; researcher Anna Buigues collected the prize. • IVI is simultaneously working on various research projects on ovarian rejuvenation. The award by the SRI- Society for Reproductive Investigation – refers to the infusion of bone marrow derived stem cells into the ovary…. View Article
This work presents for the first time a study of this nature, which involve humans, and not mammals, as in the past. To conduct the study, environmental particle concentrations have been artificially transferred into the embryo culture media. During the study, it was observed that the presence of benzene and limonene, in certain amounts, may… View Article
Male factor infertility accounts for 40% of all infertility cases. According to the results of the clinical trial, the test has an accuracy of 95%. It is the first valid home test that measures not only sperm count but also sperm progressive motility. SAN ANTONIO (USA), OCTOBER 2017 IVI, global leader in assisted fertility treatment,… View Article
The man is the main cause in 40% of infertility cases There is a correlation between low sperm quality due to chromosomal and genetic abnormalities and a low pregnancy rate Two simple tests would improve the diagnosis of male factor cases GENEVA, JULY 4th 2017 It is estimated that 15% of the world’s population have… View Article
A study reveals similar results for oocyte vitrification and ovarian cortex cryopreservation, indistinctly, to preserve fertility The study, conducted by IVI and La Fe Hospital of Valencia, dates back from 2012, when both institutions established a common flow of patients for both treatments Results show that both techniques are expected to be equally effective but… View Article
ACCREDITED CLINICAL TRAINING PROGRAMME SPONSORED BY IVI FOUNDATION AND FERRING PHARMACEUTICALS GENEVA, JULY 2nd 2017 – IVI today announced the launch of its annual fellowship programme IVI-FER, for the second year running. The fellowship launched in 2016, is a tailored, accredited clinical training programme open to young clinicians across Europe specialising in obstetrics and gynaecology. The… View Article
Beginning around the age of 40, testosterone decreases in men Late hypogonadism or “male menopause” does not totally suppress sperm production, although it may affect fertility Erectile dysfunction, reduced libido and weight gain are some of the symptoms VALENCIA, JUNE 14, 2017 Late-onset hypogonadism or androgenic deficit is characterized by a decline in testosterone levels in… View Article